Managing Director

Fortive Corporation reported 6.7% core revenue growth in Q2 2026, driven by its "Fortive Accelerated" strategy focusing on innovation and recurring customer value. The company raised its full-year adjusted EPS guidance to $2.95–$3.05 and increased core growth expectations to approximately 4%, up from 2–3%. Gross margin reached 63%, down 100 basis points year-over-year due to product mix. North America performed strongly, whilst EMEA faced modest declines from macroeconomic uncertainty. Fortive executed approximately $200 million in share repurchases during Q2, totalling 11% of shares retired since launching "New Fortive" one year ago. The company acquired a majority stake in UV Smart to expand its medical disinfection portfolio. Key innovations included Gordian's Flash AI solution for construction cost estimating and FDA clearance for ASP's 50-pound expanded load capacity in robotic-assisted surgery.

Fortive Corporation reported strong second quarter 2026 results, with core revenue growth accelerating to 6.7% and adjusted earnings per share rising 28%. The company posted revenue of $1.10 billion, up 7.9% year-over-year, and adjusted EBITDA of $323 million, up 12%. President and CEO Olumide Soroye said the company completed approximately $200 million in share repurchases during the quarter, bringing total buybacks over the past four quarters to roughly $2 billion. Based on the strong first-half performance, Fortive raised its full-year 2026 adjusted earnings per share guidance range to $2.95 to $3.05. The company's Intelligent Operating Solutions segment generated $758 million in revenue, whilst Advanced Healthcare Solutions brought in $339 million. Operating cash flow reached $299 million for the quarter, with free cash flow of $271 million.

Fortive Q2 earnings call highlights. July 29, 2026 Key points. * Fortive delivered strong second-quarter results, with 6.7% core revenue growth, 12% adjusted EBITDA growth and a 28% increase in adjusted EPS to $0.74. Performance was led by Intelligent Operating Solutions and continued demand for Fluke's data-center products. * The company generated approximately $270 million in quarterly free cash flow and repurchased about $200 million of shares, bringing buybacks since the "New Fortive" launch to nearly $2 billion. Fortive also acquired a majority stake in UV Smart to expand its healthcare disinfection portfolio. * Fortive raised its 2026 outlook, now forecasting adjusted EPS of $2.95-$3.05, reported revenue of roughly $4.35 billion and core revenue growth of about 4%, up from its previous 2%-3% estimate. * MarketBeat previews top five stocks to own in August. Fortive NYSE: FTV reported second-quarter 2026 results that included 6.7% core revenue growth, 12% adjusted EBITDA growth and a 28% increase in adjusted earnings per share, prompting the company to raise its full-year adjusted EPS outlook. President and CEO Olumide Soroye said the quarter marked continued execution of the company's "Fortive Accelerated" strategy, which emphasizes innovation, commercial investments, recurring customer value and disciplined capital allocation. Fortive generated nearly $1.1 billion in revenue, up almost 8% on a reported basis, while adjusted EPS rose to $0.74. "Q2 marked another quarter of strong results and execution," Soroye said, noting that the company has now produced four consecutive quarters of double-digit adjusted EPS growth. Revenue growth across segments. CFO Mark Okerstrom said growth reflected both price and volume gains in Fortive's two operating segments. North America remained the company's strongest region, while growth in Asia-Pacific and Latin America more than offset a modest revenue decline in Europe, the Middle East and Africa. Management attributed the EMEA weakness to geopolitical tensions and continued economic softness in the region. Intelligent Operating Solutions revenue grew about 9% on a reported basis and 7.4% organically. The segment benefited from growth across professional instrumentation, facilities and asset lifecycle solutions, and gas detection products. Segment adjusted EBITDA increased 12% to $264 million, while adjusted EBITDA margin expanded roughly 100 basis points to just under 35%. Fluke recorded strong order volume, with orders growing modestly faster than revenue. Soroye said North American sell-through remained strong and that the business exited the quarter with improved channel inventory. Growth in Europe was affected by deferred purchases from a small number of channel customers, though management said point-of-sale trends in the region were the strongest seen in six quarters. Fluke also continued to benefit from its focus on data centers. Demand for the company's CertiFiber Max product exceeded expectations, according to management. The product is intended to speed fiber-cable certification for data center construction, and Fortive said it has also helped drive demand for Fluke's broader portfolio of power quality, battery testing and diagnostic products. Advanced Healthcare Solutions generated nearly $340 million in revenue, up 6% year over year and 5.3% on a core basis. Growth was supported by healthcare consumables, services and software sales in Latin America, Asia-Pacific and North America. Segment adjusted EBITDA rose about 3% to $88 million, although adjusted EBITDA margin declined approximately 80 basis points to 26%. Management said ASP's consumables and services business expanded in every major region, while low-temperature sterilization capital-equipment demand improved and returned to growth. Soroye said hospital capital budgets remain under pressure but have continued to improve. The company also cited strong provider demand for its gastrointestinal case documentation software. Margins, cash flow and tariff refunds. Fortive's adjusted gross margin was 63%, down about 100 basis points from a year earlier, primarily because of product mix. Okerstrom said certain lower-margin products posted outsized growth, including products serving multi-site retail customers within Intelligent Operating Solutions. In healthcare, margin was affected by resumed growth in ASP capital products and strategic investments tied to larger accounts. Despite gross-margin pressure, consolidated adjusted EBITDA increased to $323 million and adjusted EBITDA margin expanded about 110 basis points to 29.5%. The company credited adjusted gross-profit growth, operating leverage and structural cost savings, partly offset by investments in its growth strategy. Fortive generated roughly $270 million of free cash flow during the quarter. Trailing 12-month free cash flow exceeded $1 billion, with conversion on net income "well north of 100%," Okerstrom said. The company recognized a $4.5 million benefit from refunds tied to IEEPA tariffs in its GAAP earnings. Fortive expects an additional $20 million to $25 million in tariff refunds in coming quarters, but excludes those refunds from adjusted metrics to facilitate comparisons between reporting periods. Capital allocation, AI and acquisitions. Fortive repurchased roughly $200 million of shares in the second quarter. Since the launch of "New Fortive" a year earlier, the company has deployed nearly $2 billion toward buybacks, repurchasing approximately 38 million shares, or about 11% of shares outstanding. Fortive also acquired a majority stake in UV Smart, whose UVC high-level disinfection technology expands ASP's disinfection portfolio for specialized instruments. Management said future bolt-on acquisitions will likely be concentrated in the company's largest platforms, including Fluke and ASP, while software acquisitions would need to meet strict strategic and financial criteria. The company highlighted artificial intelligence-enabled offerings across its software businesses, including predictive-maintenance tools at ServiceChannel and Accruent, Flash AI at Gordian, and new capabilities in Fluke's eMaint platform. Soroye said Fortive's AI investments have been supported by an internal AI Center of Excellence established seven years ago and have not required significant incremental spending. Outlook raised. Fortive raised its 2026 adjusted EPS guidance to a range of $2.95 to $3.05. The company now expects full-year reported revenue of approximately $4.35 billion and core revenue growth of about 4%, compared with its prior expectation of 2% to 3% growth. Management expects third-quarter revenue to follow normal seasonal patterns, with adjusted EBITDA margin slightly below second-quarter levels because of lower absolute revenue and modest strategic investments. Fourth-quarter reported revenue will be affected by four fewer selling days than the prior-year period, which Fortive expects will create a $15 million to $20 million revenue headwind and a 150-basis-point headwind to core growth. Okerstrom said Fortive expects to continue operating within its targeted annual adjusted EBITDA margin expansion range of 50 to 100 basis points in 2026 and 2027. About Fortive (NYSE:FTV). Fortive Corporation NYSE: FTV is a diversified industrial technology company headquartered in Everett, Washington. The company was created through a spin-off from Danaher Corporation in 2016 and has since focused on building a portfolio of professional instrumentation and industrial technology businesses. In 2020 Fortive completed a further portfolio separation with the spin-off of Vontier, concentrating Fortive's activities on higher-margin instrumentation, software and services. Fortive's operations center on professional test and measurement, sensing and monitoring, software-enabled solutions, and lifecycle services that support industrial and commercial customers. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Fortive, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fortive wasn't on the list. While Fortive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain - combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.